Sir Christopher Gent, chairman of GlaxoSmithKline, says he has identified up to four internal candidates to succeed JP Garnier, the ebullient CEO who is due to retire in October 2007. So, at least three disappointed executives there then!
Insider believes front runners will include chief operating officer David Stout, who analysts regard as Garnier's preferred choice. Chris Viehbacher, head of the drug maker's American business, and Andrew Whitty, responsible for European operations, are also likely to be on the short list. Russell Greig, credited with helping boost GSK's pipeline by buying the marketing rights to several important drugs, may also be in the frame.
External candidates should plan to "bump into" Sir Christopher asap.
Next year JPG should perhaps look to Sir Tom McKillop, outgoing CEO of AZ, for some pointers on how to wind down in preparation for the retirement home. Sir Tom is planning a new career in the banking world. Insider understands this doesnt involve either a move to India or any call centre work!
Source: The Times
No comments:
Post a Comment